Imagen de Portada

Exciting science from the 16th International Conference on Thalassemia and Hemoglobinopathies

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Dimitrios Farmakis, Michael Angastiniotis, Androulla Eleftheriou
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	HemaSphere
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

TIF Guidelines for the Management of Transfusion‐Dependent β‐Thalassemia
por: Khaled M. Musallam, et al.
Publicado: (2025)

Annual Sickle Cell & Thalassaemia Conference (ASCAT) ‐ October 2023
Publicado: (2024)

Implementation science in hemato‐oncology molecular diagnostics in France via the Groupe des Biologistes Moléculaire des Hémopathies Malignes (GBMHM)
por: Jean‐Michel Cayuela, et al.
Publicado: (2025)

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
por: Fabio Efficace, et al.
Publicado: (2024)

Enhanced potency of immunotherapy against B‐cell precursor acute lymphoblastic leukemia by combination of an Fc‐engineered CD19 antibody and CD47 blockade
por: Denis M. Schewe, et al.
Publicado: (2024)

Single‐cell analysis of MYD88L265P and MYD88WT Waldenström macroglobulinemia patients
por: Tina Bagratuni, et al.
Publicado: (2024)

The role of trephine bone marrow biopsies in the era of measurable residual disease — Results from the CLL10 trial of the German CLL Study Group (GCLLSG)
por: Nadine Kutsch, et al.
Publicado: (2024)

Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 study
por: Michael H. Tomasson, et al.
Publicado: (2024)

Lower efficacy of transfusion of red blood cells from donors with sickle cell trait
por: Monika Dzieciatkowska, et al.
Publicado: (2026)

Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
por: Sibylle Cocciardi, et al.
Publicado: (2025)

Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study
por: Meral Beksac, et al.
Publicado: (2026)

Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey
por: Claire N. Harrison, et al.
Publicado: (2025)

Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
por: Frank G. Rücker, et al.
Publicado: (2024)

Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium
por: Cristina A. Tentori, et al.
Publicado: (2024)

Sequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network
por: Niels W. C. J. van de Donk, et al.
Publicado: (2025)

Cell‐free DNA for detection and monitoring of extramedullary AML relapse
por: Henri C. Hupe, et al.
Publicado: (2025)

Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer
por: Christian Brieghel, et al.
Publicado: (2025)

Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group
por: Pierre Sesques, et al.
Publicado: (2026)

Liver iron concentration thresholds: Where do they really come from?
por: Lukas Müller, et al.
Publicado: (2025)

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry
por: Inés Gómez‐Seguí, et al.
Publicado: (2025)

Comparative analysis of macrophage feeder systems reveals distinct behaviors and key transcriptional shifts in chronic lymphocytic leukemia cells via coculture
por: Viktoria Kohlhas, et al.
Publicado: (2025)

Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL
por: Alfredo Rivas‐Delgado, et al.
Publicado: (2024)

Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era
por: Abdul‐Hamid Bazarbachi, et al.
Publicado: (2025)

Hematology in times of crisis: Lessons learned and strategic priorities from the EHA–ASH Joint Workshop on Ukraine
por: Oleksandr Istomin, et al.
Publicado: (2026)

Pharmacological inhibition of sclerostin protects bone from B‐cell acute lymphoblastic leukemia‐mediated destruction
por: Vincent Kuek, et al.
Publicado: (2026)

Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV‐independent major determinant of microenvironment composition in classic Hodgkin lymphoma
por: Berit Müller‐Meinhard, et al.
Publicado: (2024)

Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia
por: Bela Patel, et al.
Publicado: (2024)

Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry
por: David F. Moreno, et al.
Publicado: (2024)

Who owns that blood? Recontacting donors with results from genetic testing after allogeneic hematopoietic cell transplantation
por: Mirjam E. Belderbos, et al.
Publicado: (2025)

Clonal hematopoiesis dynamics influences long‐term outcomes of follicular lymphoma: Results from FIL FOLL12 trial
por: Nawar Maher, et al.
Publicado: (2026)

Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study
por: Sonia Morè, et al.
Publicado: (2025)

Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
por: Amira Marouf, et al.
Publicado: (2025)

Elevated serum heme oxygenase‐1 in pediatric sickle cell disease: Insights from the SickleGenAfrica Network
por: Anna M. Sowa, et al.
Publicado: (2025)

Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study
por: Alberto Bavieri, et al.
Publicado: (2024)

Mitochondrial retention in mature red blood cells from patients with sickle cell disease is associated with stress erythropoiesis but not with proinflammatory state
por: Marc Romana, et al.
Publicado: (2024)

Cumulative review of cardiac failure with acalabrutinib in the treatment of chronic lymphocytic leukemia using data from clinical trials and postmarketing experience
por: Paolo Ghia, et al.
Publicado: (2025)

Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG‐MPN bioregistry
por: Hyunyee Rosa Cho, et al.
Publicado: (2025)

Correction to Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study
Publicado: (2025)

Hypomorphic ATP11c is a novel regulator of decreased efficacy of transfused red blood cells in humans and mice
por: James C. Zimring, et al.
Publicado: (2026)

Tet2 deficiency promotes IgG1+ B‐cell expansion and differentiation blockade through deregulation of the Nfkbia –c‐Rel axis
por: Hussein Ghamlouch, et al.
Publicado: (2026)